Controlling the dose of a liver transplant rejection drug reduces the risk of developing cancer
A multi-centre study, in which the Clínic-IDIBAPS participated, identified, in nearly 2,500 transplant patients, the main risk factors for the develo1
A multi-centre study, in which the Clínic-IDIBAPS participated, identified, in nearly 2,500 transplant patients, the main risk factors for the develo1
EBRAINS is a new digital research infrastructure, created by the EU-funded Human Brain Project, which brings together a wide range of data and tools1
The activity is part of a new project of the institution to publicize the research done by IDIBAPS to patients and patient associations.
The results of the study, carried out by researchers from Hospital Clínic-IDIBAPS and CIBERES, will make it possible to design new therapies for chro1
Regenerating and protecting pancreatic beta cells, which are responsible for producing and secreting insulin, are two of the areas of research being1
Treatment with gene therapy, however, reverses the damage caused by deposits of α-synuclein in the neuron circuits and alleviates neuropsychiatric sy1
The document establishes the basis for the exploitation and development of patented technology, owned by six research centers, including IDIBAPS.
Researchers from the Hospital Clínic-IDIBAPS, the Research Institute of the Hospital de Sant Pau – IIB Sant Pan and the CIBERER confirm that the mole1
Researchers from the Hospital Clínic-IDIBAPS, IDIBELL and CIBERSAM have developed a smartphone app that allows anxiety to be assessed continuously an1
Researchers at Hospital Clínic-IDIBAPS have observed changes in the phosphorylation pattern of certain proteins associated with a mutation in the gen1